Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma.

@article{Charbonneau2013ExpressionOF,
  title={Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma.},
  author={Bridget Charbonneau and Rachel Isaksson Vogel and Juan Carlos Manivel and Anthony E. Rizzardi and Stephen C. Schmechel and Simona Ognjanovic and Subbaya Subramanian and David A. Largaespada and Brenda Weigel},
  journal={Human pathology},
  year={2013},
  volume={44 9},
  pages={1918-26}
}
Although rare, synovial sarcoma (SS) is one of the most common soft tissue sarcomas affecting young adults. To investigate potential tumor markers related to synovial sarcoma prognosis, we carried out a single-institution retrospective analysis of 103 patients diagnosed with SS between 1980 and 2009. Clinical outcome data were obtained from medical records, and archived tissue samples were used to evaluate the relationship between progression-free survival (PFS) and several prognostic factors… CONTINUE READING